5 completed. 5 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
| Phase 1 | 1 | Completed 1 |
Follow Magnetic Resonance Imaging: new trials by email Literature Review of Magnetic Resonance Imaging trials Research Report on Magnetic Resonance Imaging
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cardiovascular Contrast-enhanced Magnetic Resonance Imaging Using Polysaccharide Superparamagnetic Iron Oxide Injection in Diabetic Patients Polysaccharide superparamagnetic iron oxide injection - Diabetes, Magnetic Resonance Imaging | Phase 1 / Phase 2 | Completed | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 12 | 2021-11-06 | 2023-09-29 |
| Corticosteroid Effects on Asymptomatic Gadolinium-enhancing Lesions in Multiple Sclerosis Methylprednisolone succinate, Normal saline - Multiple Sclerosis, Relapsing-Remitting, Magnetic Resonance Imaging | Phase 2 | Completed | Mazandaran University of Medical Sciences | 102 | 2021-05-22 | 2025-07-15 |
| The Clinical Validity and Safety of IOP Injection MRI Contrast Agent in Hepatocellular Carcinoma IOP Injection (MPB-1523) - Magnetic Resonance Imaging | Phase 2 | Completed | MegaPro Biomedical Co. Ltd. | 52 | 2018-11-22 | 2021-10-22 |
| Axillary Plexus Block in a High Resolution MRI Active Comparator: Arm 1: catheter injection, Active Comparator: Arm 2: transarterial injection, Active Comparator: Arm 3: catheter and transarterial injection - Nerve Block, Magnetic Resonance Imaging | Phase 2 | Completed | Diakonhjemmet Hospital | 45 | 2009-01-01 | 2014-02-13 |
| Myocardial Perfusion MRI Gadobutrol (Gadavist,Gadovist, BAY86-4875) - Myocardial Perfusion Imaging, Magnetic Resonance Imaging | Phase 2 | Completed | Bayer | 232 | 2004-03-01 | 2014-05-22 |
Carcinoma, Hepatocellular (1) · Diabetes Mellitus (1) · Multiple Sclerosis (1) · Multiple Sclerosis, Relapsing-Remitting (1)
Adenocarcinoma (1) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Carcinoma (1) · Demyelinating Autoimmune Diseases, CNS (1) · Demyelinating Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Immune System Diseases (1) · Liver Diseases (1) · Liver Neoplasms (1) · Metabolic Diseases (1) · Neoplasms (1)
Exercise (1) · Methylprednisolone Hemisuccinate (1) · Saline Solution (1) · gadobutrol (1)
Bayer (1) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1) · Diakonhjemmet Hospital (1) · Mazandaran University of Medical Sciences (1) · MegaPro Biomedical Co. Ltd. (1)
Austria (1) · China (1) · Germany (1) · Iran (1) · Norway (1) · Poland (1) · Switzerland (1) · Taiwan (1)
Chien-Hung Chen, MD (1) · David Wang, MD (1) · Seyed Mohammad Baghbanian, Dr. (1) · Trygve TK Kjelstrup, MD (1)
2005 (1)